Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EBT (2020 - 2025)

Biofrontera (BFRI) has 6 years of EBT data on record, last reported at -$6.6 million in Q3 2025.

  • For Q3 2025, EBT fell 17.24% year-over-year to -$6.6 million; the TTM value through Sep 2025 reached -$17.5 million, down 36.9%, while the annual FY2024 figure was -$17.7 million, 11.83% up from the prior year.
  • EBT reached -$6.6 million in Q3 2025 per BFRI's latest filing, down from -$5.3 million in the prior quarter.
  • Across five years, EBT topped out at $5.6 million in Q1 2022 and bottomed at -$16.0 million in Q3 2021.
  • Average EBT over 5 years is -$4.9 million, with a median of -$4.2 million recorded in 2025.
  • Peak YoY movement for EBT: crashed 7612.77% in 2021, then skyrocketed 258.25% in 2022.
  • A 5-year view of EBT shows it stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then skyrocketed by 226.44% to $3.5 million in 2023, then plummeted by 139.74% to -$1.4 million in 2024, then tumbled by 374.84% to -$6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$6.6 million in Q3 2025, -$5.3 million in Q2 2025, and -$4.2 million in Q1 2025.